Deals
Marina Biotech Raises $6M in Conv Preferred Deal at 41% Discount
|
Marina Biotech, Inc. (MRNA) announced that it has raised $6,000,000 in a Convertible Preferred Stock transaction. The fixed conversion price of the Convertible Preferred Stock is $0.75 per share, an approximate 40.94% discount to the market price ($1.27) of MRNA at deal announcement. A series of 6,000,000 60-Month Warrants with an exercise price of $0.75 per share (40.94% discount) was issued to the investors in this transaction. Note this Placement is subject to customary closing conditions and is expected to close by 03/07/2014. via PlacementTracker.